Balchem closed at $168.68 on Sep 28, up 0.47%, 8.0% below its 52-week closing high. Volume of 172.5K shares was 0.81× its 20-day average (close to normal).
Split-adjusted performance: -5.2% over one month, +1.0% over six months, +12.4% over one year.
In the quarter ended Jun 30, 2026, revenue was $284M, up 11.2% from a year earlier, with a net margin of 15.7%.
Short interest was 620.0K shares at the Sep 15 settlement, up 11.8% from the prior report (2.0% of float, 3.3 days to cover).